The process typically starts with the removal of T cells from the patient's blood. These cells are then genetically modified or selected for their ability to target cancer cells. Once the T cells are prepared, they are multiplied in the laboratory to create a large population of cancer-fighting cells. These enhanced T cells are then infused back into the patientâs body, where they seek out and destroy cancer cells.